The Uncommon Engineer - The Goals of Santangelos Research @GeorgiaTechCoE
The Uncommon Engineer - The Goals of Santangelos Research  @GeorgiaTechCoE
Uploaded December 2019 | Updated November 2026, 4 days ago
Dr. Phil Santangelo is professor in Coulter Department of Biomedical Engineering. His research is focused on treating diseases like HIV through RNA-based therapies, and he’s getting close to delivering an HIV preventative for women.

#CreatingTheNext #UncommonEngineer

Follow Georgia Tech's College of Engineering on Social Media: Facebook: facebook.com/GTengineering
Twitter: twitter.com/gatechengineers
Instagram: instagram.com/gatechengineers
YouTube: youtube.com/user/coegatech
Follow Dean Steve McLaughlin on social media:
Twitter: twitter.com/gtengineerdean

The Georgia Tech College of Engineering is creating tomorrow's leaders in engineering, science and technology. It offers internationally renowned programs in the heart of Atlanta, giving students opportunities for research and real-world experience, and its focus on innovation gives graduates an edge. The College awards more engineering degrees to women and underrepresented minorities than any other institution in the United States, and as part of a public university, it remains an excellent value for an elite engineering education.

Learn more about Georgia Tech ( http://www.gatech.edu/ ) and the College of Engineering ( https://coe.gatech.edu/ ).
The Uncommon Engineer - The Goals of Santangelos ResearchClean Water | Engineered at Tech (Episode 2)Wearable RoboticsEllen Chen Mazumdar - Sensing Technologies LaboratorySeven Days After DeploymentElephant Using Trunk to Grab ApplesThe Uncommon Engineer - Engineers Turned Entrepreneurs: The Nunnally TwinsExit Interview - Antonia RabishevaThe Uncommon Engineer: Nuclear Proliferation and Detection with Anna EricksonThe Uncommon Engineer - HIV Preventatives with RNA with Phil Santangelo50 Hours After DeploymentWhy NRE at GT?
Georgia Tech College of Engineering |

The Uncommon Engineer - The Goals of Santangelo's Research

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER